Nimustine
- Generic Name
- Nimustine
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C9H13ClN6O2
- CAS Number
- 42471-28-3
- Unique Ingredient Identifier
- 0S726V972K
- Background
Nimustine has been used in trials studying the treatment of Glioblastoma.
- Indication
适用于脑瘤、肺癌、慢性白血病、恶性淋巴瘤、消化道癌。
- Associated Conditions
- -
- Associated Therapies
- -
Bevacizumab and Nimustine in Patients With Recurrent High Grade Glioma
- First Posted Date
- 2016-03-03
- Last Posted Date
- 2018-07-31
- Lead Sponsor
- Huashan Hospital
- Target Recruit Count
- 23
- Registration Number
- NCT02698280
- Locations
- 🇨🇳
Huashan hospital, Fudan University, Shanghai, Shanghai, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath